Ireland-based medical device firm EMBA Medical has received CE mark approval for its Hourglass Peripheral Embolization Plug, which was designed for peripheral embolization procedures.
The company has designed Hourglass Peripheral Embolization Plug to offer precise, secure, over-the-wire delivery and immediate occlusion with a single integrated device.
EMBA Medical CEO George Wallace said: "The goal with over-the-wire design is to provide physicians with accurate, stent-like delivery of the device in the vessel.
"We believe that the Hourglass implant will provide a level of confidence, precision, and control for peripheral embolization procedures that physicians have come to enjoy over the years while performing other types of over-the-wire endovascular procedures."
According to Hourglass co-developer Dr Andrew Cragg, the new device will provide immediate occlusion in a wide range of vessel sizes with a single device.
The device’s design will allow to take advantage of natural hemodynamic forces to offer immediate, focal and stable occlusions, said Cragg.
The Hourglass Peripheral Embolization Plug is a class IIb medical device, which will be produced at the firm’s manufacturing facility in Miramar of Florida, US.
The device has not yet received approval in the US.